Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Respiratory chain complex I deficiency.

R H Triepels1, L P Van Den Heuvel, J M Trijbels

  • 1Nijmegen Center for Mitochondrial Disorders, University Medical Center Nijmegen, The Netherlands.

American Journal of Medical Genetics
|October 2, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency" [Biochim. Biophys. Acta. 2007;1772(9):1041-1051. PMID: 17600689].

Biochimica et biophysica acta. Molecular basis of disease·2021
Same author

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin <i>Escherichia coli</i> Induced Hemolytic-Uremic Syndrome.

Frontiers in immunology·2021
Same author

Hyperhomocysteinemia: a trigger for complement-mediated TMA?

Acta clinica Belgica·2019
Same author

Diagnosis and treatment of C3 glomerulopathy in a center of expertise.

The Netherlands journal of medicine·2019
Same author

Genotype-phenotype correlations of low-frequency variants in the complement system in renal disease and age-related macular degeneration.

Clinical genetics·2018
Same author

Mild intracellular acidification by dexamethasone attenuates mitochondrial dysfunction in a human inflammatory proximal tubule epithelial cell model.

Scientific reports·2017
Same journal

Abstracts for the Xth World Congress of Psychiatric Genetics. Brussels, Belgium, 9-13 October 2002.

American journal of medical genetics·2003
Same journal

Defects of blastogenesis.

American journal of medical genetics·2002
Same journal

Malformations of the craniofacial region: evolutionary, embryonic, genetic, and clinical perspectives.

American journal of medical genetics·2002
Same journal

Limb anomalies: Developmental and evolutionary aspects.

American journal of medical genetics·2002
Same journal

Molecular etiology of gut malformations and diseases.

American journal of medical genetics·2002
Same journal

Status of the human malformation map: 2002.

American journal of medical genetics·2002
See all related articles

Isolated complex I deficiency, a common cause of oxidative phosphorylation disorders, presents diverse clinical phenotypes. Further research is crucial to identify the genetic causes of remaining cases.

Area of Science:

  • Biochemistry
  • Genetics
  • Mitochondrial Biology

Background:

  • Oxidative phosphorylation disorders affect 1 in 10,000 live births, with isolated complex I deficiency being a frequent cause.
  • Complex I (NADH:ubiquinone oxidoreductase) is the largest enzyme complex in the mitochondrial electron transport chain.
  • Complex I deficiency often leads to multi-system disorders with high early mortality.

Purpose of the Study:

  • To review recent clinical, biochemical, and molecular advances in complex I deficiency.
  • To highlight the significant proportion of cases with unknown genetic causes.
  • To present novel strategies for identifying disease-causing genes and understanding human complex I composition.

Main Methods:

  • Literature review of recent advances in complex I deficiency.

Related Experiment Videos

  • Analysis of clinical, biochemical, and molecular data.
  • Discussion of novel genetic research strategies and complex I molecular composition.
  • Main Results:

    • Recent advances have improved understanding of complex I deficiency's clinical, biochemical, and molecular aspects.
    • Genetic defects remain unidentified in approximately 60% of complex I deficiency cases.
    • Novel strategies are being explored to discover disease-causing genes and elucidate complex I structure.

    Conclusions:

    • Despite progress, a substantial knowledge gap exists regarding the genetic etiology of complex I deficiency.
    • Continued research is essential to identify genetic defects in remaining cases.
    • Exploring non-structural nuclear-encoded genes and detailed molecular composition is key for future discoveries.